Spasm-Controlled Lateral Internal SphincterotomyLateral Internal Sphincterotomy up to Fissure ApexLateral Internal Sphincterotomy up to Dentate Line
Spasm-Controlled Lateral Internal Sphincterotomy: Serial small open sphincterotomies under local anesthesia plus IV sedation using an anal calibrator until anal caliber of 30 mm is achieved.
Lateral Internal Sphincterotomy up to Fissure Apex: Open LIS extended to the proximal end of the fissure under spinal or general anesthesia.
Lateral Internal Sphincterotomy up to Dentate Line: Open LIS extended to the level of the dentate line under spinal or general anesthesia.
Study summary
This prospective randomized controlled trial compares three lateral internal sphincterotomy (LIS) techniques in patients with chronic anal fissure refractory to medical treatment: (1) Spasm-Controlled LIS (serial small sphincterotomies using an anal calibrator until 30 mm anal caliber is achieved, under local anesthesia plus sedation), (2) LIS up to the Fissure Apex (spinal or general anesthesia), and (3) LIS up to the Dentate Line (spinal or general anesthesia). The primary outcomes are fissure healing rate and fecal incontinence incidence at 12 months, assessed using the Wexner Incontinence Score. Secondary outcomes include postoperative pain (VAS), recurrence rate, patient satisfaction, and complications. A total of 150 patients (50 per group) will be enrolled and followed for 12 months.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age 18 years or older
* Diagnosis of chronic anal fissure (duration ≥8 weeks)
* Failure to heal after at least 6 weeks of appropriate medical treatment (topical agents, fiber supplementation, sitz baths)
* Complete preoperative fecal continence (Wexner Incontinence Score = 0)
* Primary anal fissure (posterior or anterior midline location)
* Written informed consent
Exclusion Criteria:
* Any degree of preoperative fecal incontinence
* Secondary anal fissure (associated with Crohn's disease, tuberculosis, HIV, syphilis, or other systemic conditions)
* Previous anal sphincter surgery
* History of obstetric sphincter injury
* Active anorectal infection (abscess or fistula)
* Pregnancy or breastfeeding
* Uncorrectable coagulopathy or current anticoagulant use
* Inability to cooperate with study procedures or attend follow-up visits
Primary outcome measure(s)
Fissure Healing Rate — 12 months Complete epithelialization of the anal fissure with no symptoms at 12 months postoperatively, assessed by clinical examination.
Fecal Incontinence Incidence — 12 months Incidence of de novo fecal incontinence assessed using the Wexner (Cleveland Clinic) Incontinence Score. A score increase of ≥1 point from preoperative baseline is defined as de novo incontinence.
Trial sites (1)
Facility
City
Region
Status
Canakkale Onsekiz Mart University
Çanakkale
Çanakkale
Recruiting
More Çanakkale Onsekiz Mart University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.